Boston, MA 06/26/2013 (wallstreetpr) – The prospects of Walgreen Company (NYSE:WAG) had been reported to be bright for the near future, as reported by the analysts despite poor earnings reported by the company which had missed the expectations of experts. The analysts had also reported that the long term prospects of the Deerfield based Walgreen Company (NYSE:WAG) are bright and prosperous.
The third quarter earnings of the fiscal year 2013 had been reported to be 85 cents per basic and diluted share after adjusting for expenses such as acquisition and legal costs, while the analysts had forecast an adjusted earnings per share for Walgreen Company (NYSE:WAG) at 91 cents. The lowered earnings per share for the third quarter had been primarily attributed by the company to poor sales of its products outside its own pharmacies, which had not met the expectations of the company.
In addition, Walgreen Company (NYSE:WAG) had also decreased the financial guidance for the earnings contribution to be made by Alliance Boots, the European health and beauty retailer for the fourth quarter. The shares of Walgreen Company (NYSE:WAG) had witnessed a decline in prices by 5.89 percent for the trading session on Tuesday, while the closing price for the company was recorded at $45.22 per share for the day. The company had been trading with intraday prices moving in the range of $44.04 per share to $45.08 per share during the trading session on Tuesday. The shares of Walgreen Company (NYSE:WAG) had recorded 52 week low price level at $28.82 per share and 52 week high price level at $51.25 per share.
Walgreen Company (NYSE:WAG) presently had reported an average trading volume at 4.99 million shares per day. The company operates with 63 percent of its capital under the institutional ownership and presently has 947.49 million shares outstanding in the market. The present market capitalization of the company is at $42.85 billion.
